INSIGHTS ON DRUG DEVELOPMENT
-
EMA Support For SMEs Through Scientific Advice And Early Dialogue
Discover how early engagement with European regulators helps smaller drug developers reduce uncertainty, clarify requirements, and deārisk innovative programs through early dialogue.
-
Introducing 2 New Highly Effective ADC Payloads For Cancer Therapeutics
Unlock the potential of antibody-drug conjugates (ADCs) by exploring our novel payloads, designed for easy access and evaluation, to accelerate your ADC drug development with proven efficacy and safety.
-
Expanding The OSD Toolbox: An Industry Approach To Adsorb Lipids Onto Powder Substrates
Explore innovative solutions for improving the solubility and bioavailability of poorly soluble compounds in solid oral dosage forms to enhance drug delivery and therapeutic effectiveness.
-
Robust Database Characterizes And Optimizes Product Development
Integrating material characterization data with process parameters accelerates drug development, reduces empirical testing, and strengthens regulatory compliance.
-
In Vitro Drug Screening On Cancer Cells10/29/2025
Explore a high-throughput assay combining stain-free imaging and multiplexed viability/toxicity measurements to evaluate drug effects on cancer cells, ideal for labs optimizing cell-based screening.
-
mRNA Vaccines And Therapeutics: Current Trends And Perspectives2/25/2025
Delve into the advancements and transformative impact of mRNA vaccine technology on modern medicine and explore how this technology is revolutionizing healthcare for the future and beyond.
-
From Automation Islands To Connected Plants: A Practical Path For Life Sciences Manufacturers5/19/2026
Fragmented automation slows data flow and strips context from it. Life sciences manufacturers are moving toward connected plants, where integrating control, execution, scheduling, and knowledge systems is becoming a baseline expectation.
-
Design Scalable Downstream Processes With Practical Strategies5/11/2026
Downstream purification is becoming more complex as new modalities enter development. Learn how advanced analytics and chromatography strategies can support scalable, confident process development.
-
How Adept Formulation Helps Overcome Manufacturability Challenges6/17/2026
Initial development, scaleup, and tech transfer of complex multi-particulate drug systems requires meticulous planning to mitigate manufacturing risks.
DRUG DEVELOPMENT SOLUTIONS
-
Oral dose development, manufacturing, packaging, and serialization under one quality system, supporting potent and controlled compounds from clinical supply through commercial launch.
-
Waters has a complete portfolio of liquid chromatography and LC-MS solutions to provide you with accurate data to answer your lab's most pressing questions.
-
Waters MaxPeak Premier Columns and Solutions dramatically reduce NSA with MaxPeak High Performance Surfaces, innovative technologies designed to reduce analyte loss due to analyte/surface interactions.
-
Enhance dissolution and lubrication in solid oral formulations. See how this approach supports poorly soluble actives, modern manufacturing methods, and consistent performance.
-
Minimize variability and improve detection confidence with high-purity analytical solvents. Discover how tightly controlled specifications support cleaner baselines and more reliable results.